The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients

被引:9
作者
Chen, Jihui [1 ]
Huang, Xiaohui [1 ]
Bu, Shuhong [1 ]
Chen, Xiaoxiao [2 ]
Zhou, Jia [1 ]
Liu, Xinzhu [1 ]
Guo, Xiaowen [1 ]
Li, Lixia [1 ]
Zhang, Jian [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Hematol Oncol, Shanghai, Peoples R China
关键词
area under the concentration-time curve; pediatric patients; pharmacokinetics; trough concentration; vancomycin; STAPHYLOCOCCUS-AUREUS INFECTIONS; HEALTH-SYSTEM PHARMACISTS; DISEASES SOCIETY; AMERICAN SOCIETY; CHILDREN; PHARMACOKINETICS; GUIDELINES;
D O I
10.1002/prp2.885
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To assess the pharmacokinetic parameters of vancomycin in Chinese critically ill pediatric patients, children treated with vancomycin, hospitalized in the intensive care unit were included. Samples to determine peak and trough serum concentrations were obtained on the third day of treatment. Half-life was significantly longer in neonates and showed a decreasing trend in infants and children. In patients aged >= 1 month, AUC(24)/MIC >= 400 was achieved in 31.8% at the dose of 40 mg/kg/d, and in 48.7% at the dose of 60 mg/kg/d with an assumed MIC of 1 mg/L. Augmented renal clearance (ARC) was present in 27.3% of children, which was associated with higher vancomycin clearance and lower AUC values. A good correlation was observed between trough concentration and AUC(24), and the trough concentration that correlated with AUC(24) of 400 were varied according to the dosage regimens, 8.42 mg/L for 6-hintervals, and 6.63 mg/L for 8-h intervals. To conclude, vancomycin trough concentration that related to the AUC(24) of 400 was much lower in critically ill children than that in adults. The dosage of 60 mg/kg/day did not enough for producing AUC(24) in the range of 400-600 mg h/L in critically ill children, especially in those with ARC.
引用
收藏
页数:9
相关论文
共 31 条
[1]   Optimizing the Clinical Use of Vancomycin [J].
Alvarez, Rocio ;
Lopez Cortes, Luis E. ;
Molina, Jose ;
Cisneros, Jose M. ;
Pachon, Jeronimo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) :2601-2609
[2]   Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study [J].
Ayuthaya, Satja Issaranggoon Na ;
Katip, Wasan ;
Oberdorfer, Peninnah ;
Lucksiri, Aroonrut .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 92 :151-159
[3]   Augmented Renal Clearance in Critically Ill Patients: A Systematic Review [J].
Bilbao-Meseguer, Idoia ;
Rodriguez-Gascon, Alicia ;
Barrasa, Helena ;
Isla, Arantxazu ;
Angeles Solinis, Maria .
CLINICAL PHARMACOKINETICS, 2018, 57 (09) :1107-1121
[4]   An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents [J].
Broome, Laura ;
So, Tsz-Yin .
INTERNATIONAL JOURNAL OF PEDIATRICS, 2011, 2011
[5]   Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants [J].
Chen, Yewei ;
Wu, Dan ;
Dong, Min ;
Zhu, Yiqing ;
Lu, Jinmiao ;
Li, Xiaoxia ;
Chen, Chao ;
Li, Zhiping .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (07) :921-930
[6]   Augmented Renal Clearance [J].
Cook, Aaron M. ;
Hatton-Kolpek, Jimmi .
PHARMACOTHERAPY, 2019, 39 (03) :346-354
[7]   Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board? [J].
De Cock, Pieter A. J. G. ;
Desmet, Sarah ;
De Jaeger, Annick ;
Biarent, Dominique ;
Dhont, Evelyn ;
Herck, Ingrid ;
Vens, Daphne ;
Colman, Sofie ;
Stove, Veronique ;
Commeyne, Sabrina ;
Vande Walle, Johan ;
De Paepe, Peter .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) :801-804
[8]   Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature [J].
Hartman, Stan J. F. ;
Bruggemann, Roger J. ;
Orriens, Lynn ;
Dia, Nada ;
Schreuder, Michiel F. ;
De Wildt, Saskia N. .
CLINICAL PHARMACOKINETICS, 2020, 59 (02) :173-205
[9]   Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society [J].
He, Na ;
Su, Shan ;
Ye, Zhikang ;
Du, Guanhua ;
He, Bei ;
Li, Dakui ;
Liu, Youning ;
Yang, Kehu ;
Zhang, Xianglin ;
Zhang, Yingyuan ;
Chen, Xiao ;
Chen, Yaolong ;
Chen, Zhigang ;
Dong, Yalin ;
Du, Guang ;
Gu, Jian ;
Guo, Daihong ;
Guo, Ruichen ;
Hu, Xin ;
Jiao, Zheng ;
Li, Huande ;
Liu, Gaolin ;
Li, Zhiping ;
Lv, Yuan ;
Lu, Wei ;
Miao, Liyan ;
Qu, Jieming ;
Sun, Tieying ;
Tong, Rongsheng ;
Wang, Li ;
Wang, Minggui ;
Wang, Rui ;
Wen, Aidong ;
Wu, Jiuhong ;
Wu, Xin'an ;
Xu, Yingchun ;
Yang, Yong ;
Yang, Fan ;
Zhan, Siyan ;
Zhang, Bikui ;
Zhang, Chao ;
Zhang, Huizhi ;
Zhang, Jie ;
Zhang, Jing ;
Zhang, Jun ;
Zhang, Wenting ;
Zhao, Libo ;
Zhao, Limei ;
Zhao, Rongsheng ;
Zhao, Wei .
CLINICAL INFECTIOUS DISEASES, 2020, 71 :S363-S371
[10]   Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008-2018 [J].
Jian, Ying ;
Lv, Huiying ;
Liu, Junlan ;
Huang, Qian ;
Liu, Yao ;
Liu, Qian ;
Li, Min .
FRONTIERS IN MICROBIOLOGY, 2020, 11